Works matching IS 11738804 AND DT 2023 AND VI 37 AND IP 5

Results: 11

Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer's Perspective.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 583, doi. 10.1007/s40259-023-00619-0

By:

Cohen, Hillel P.;
Turner, Matthew;
McCabe, Dorothy;
Woollett, Gillian R.

Publication type:

Article

Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 637, doi. 10.1007/s40259-023-00618-1

By:

Lee, Wonju;
Lee, Sang Min;
Jung, Sang Taek

Publication type:

Article

Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 595, doi. 10.1007/s40259-023-00615-4

By:

Thornburg, Courtney D.;
Simmons, Dana H.;
von Drygalski, Annette

Publication type:

Article

The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 625, doi. 10.1007/s40259-023-00612-7

By:

Singh, Jasvinder A.

Publication type:

Article

Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 649, doi. 10.1007/s40259-023-00611-8

By:

Williams, Alexander H.;
Zhan, Chang-Guo

Publication type:

Article

Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 685, doi. 10.1007/s40259-023-00609-2

By:

Ditters, Imke A. M.;
van Kooten, Harmke A.;
van der Beek, Nadine A. M. E.;
Hardon, Jacqueline F.;
Ismailova, Gamida;
Brusse, Esther;
Kruijshaar, Michelle E.;
van der Ploeg, Ans T.;
van den Hout, Johanna M. P.;
Huidekoper, Hidde H.

Publication type:

Article

Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 607, doi. 10.1007/s40259-023-00608-3

By:

Cavallazzi Sebold, Bernardo;
Li, Junjie;
Ni, Guoying;
Fu, Quanlan;
Li, Hejie;
Liu, Xiaosong;
Wang, Tianfang

Publication type:

Article

In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 709, doi. 10.1007/s40259-023-00607-4

By:

Mishra, Akshay G.;
Deshmane, Rutuja B.;
Thappa, Damodar K.;
Lona, Jeseena;
Ghade, Nikhil S.;
Sonar, Sanjay M.;
Krishnan, Archana R.

Publication type:

Article

Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese Adults.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 721, doi. 10.1007/s40259-023-00604-7

By:

Li, Chen;
Liu, Haiyan;
Liao, Yixiang;
Zhu, Yu;
Tian, Jingyuan;
Wang, Xuan;
Hu, Zhiqin;
Zhan, Yaoxuan;
Li, Xianbo;
Liang, Xintong;
He, Jin;
Li, Yongmei;
Shang, Dewei;
Zheng, Qingshan;
Wang, Tenghua;
Song, Haifeng;
Fang, Yi

Publication type:

Article

Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 699, doi. 10.1007/s40259-023-00603-8

By:

Pauline, Orhon;
Robert, Marion;
Bernardeau, Claire;
Hlavaty, Alex;
Fusaroli, Michele;
Roustit, Matthieu;
Cracowski, Jean-Luc;
Khouri, Charles

Publication type:

Article

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.

Published in:

BioDrugs, 2023, v. 37, n. 5, p. 675, doi. 10.1007/s40259-023-00601-w

By:

Ciccimarra, Francesco;
Luxi, Nicoletta;
Bellitto, Chiara;
L' Abbate, Luca;
De Nardo, Pasquale;
Savoldi, Alessia;
Yeomans, Alison;
Molokhia, Mariam;
Tacconelli, Evelina;
Trifirò, Gianluca

Publication type:

Article